Cooper Companies Inc
COO82.750USD
+0.290+0.35%
Handelsschluss 12/19, 16:00（ET）Kurse um 15 Minuten verzögert
16.21BMarktkapitalisierung
43.95KGV TTM
mehr Informationen über Cooper Companies Inc Unternehmen
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Cooper Companies Inc Informationen
BörsenkürzelCOO
Name des UnternehmensCooper Companies Inc
IPO-datumJan 21, 1983
CEOWhite (Albert G)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeJan 21
Addresse6101 Bollinger Canyon Road
StadtSAN RAMON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94583
Telefon19254603600
Websitehttps://www.coopercos.com/
BörsenkürzelCOO
IPO-datumJan 21, 1983
CEOWhite (Albert G)
Führungskräfte von Cooper Companies Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Ms. Cynthia L. (Cindy) Lucchese, CPA
Ms. Cynthia L. (Cindy) Lucchese, CPA
Independent Director
Independent Director
7.66K
+55.08%
Mr. Agostino Ricupati
Mr. Agostino Ricupati
Senior Vice President - Finance and Tax, Chief Accounting Officer
Senior Vice President - Finance and Tax, Chief Accounting Officer
7.51K
+15.72%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Director
Independent Director
5.78K
+52.95%
Mr. Nicholas S. Khadder, J.D.
Mr. Nicholas S. Khadder, J.D.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
2.14K
+320.67%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%
Nach RegionUSD
Name
Umsatz
Anteil
United States
516.20M
48.68%
Europe
343.10M
32.36%
Rest of the World
201.00M
18.96%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%
Aktionärsstatistik
Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.19%
Capital World Investors
5.38%
BlackRock Institutional Trust Company, N.A.
5.02%
T. Rowe Price Investment Management, Inc.
5.01%
State Street Investment Management (US)
4.38%
Andere
68.01%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.19%
Capital World Investors
5.38%
BlackRock Institutional Trust Company, N.A.
5.02%
T. Rowe Price Investment Management, Inc.
5.01%
State Street Investment Management (US)
4.38%
Andere
68.01%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
58.31%
Investment Advisor/Hedge Fund
34.98%
Hedge Fund
6.21%
Research Firm
3.96%
Bank and Trust
1.29%
Pension Fund
1.27%
Family Office
0.91%
Family Office
0.91%
Family Office
0.70%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1362
208.96M
111.56%
-3.88K
2025Q3
1410
208.99M
111.74%
+4.12M
2025Q2
1399
205.52M
107.52%
+1.81M
2025Q1
1380
203.24M
103.36%
-3.45M
2024Q4
1357
199.65M
102.09%
+3.47M
2024Q3
1324
195.11M
102.83%
-1.38M
2024Q2
1308
196.62M
100.46%
+4.01M
2024Q1
1307
191.91M
103.85%
-14.49M
2023Q4
1291
198.78M
104.05%
+1.21M
2023Q3
1279
197.30M
102.69%
+609.87K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
24.16M
12.15%
+419.27K
+1.77%
Jun 30, 2025
Capital World Investors
8.39M
4.22%
+645.79K
+8.34%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.76M
4.91%
-120.78K
-1.22%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.38M
3.71%
+106.52K
+1.46%
Jun 30, 2025
State Street Investment Management (US)
8.66M
4.36%
+104.91K
+1.23%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
7.85M
3.95%
-130.44K
-1.63%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.21M
2.62%
+127.91K
+2.52%
Jun 30, 2025
Sustainable Growth Advisers, LP
3.39M
1.7%
+2.79M
+466.43%
Jun 30, 2025
Neuberger Berman, LLC
5.06M
2.55%
+1.46M
+40.32%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
First Trust Indxx Medical Devices ETF
2.05%
Themes US R&D Champions ETF
1.96%
Invesco Bloomberg Pricing Power ETF
1.89%
State Street SPDR S&P Health Care Equipment ETF
1.85%
Invesco S&P 500 Equal Weight Health Care ETF
1.69%
Motley Fool Mid-Cap Growth ETF
1.59%
Congress SMid Growth ETF
1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
1.19%
Pacer US Export Leaders ETF
0.95%
First Trust Health Care Alphadex Fund
0.89%
Mehr Anzeigen
First Trust Indxx Medical Devices ETF
Anteil2.05%
Themes US R&D Champions ETF
Anteil1.96%
Invesco Bloomberg Pricing Power ETF
Anteil1.89%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.85%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.69%
Motley Fool Mid-Cap Growth ETF
Anteil1.59%
Congress SMid Growth ETF
Anteil1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
Anteil1.19%
Pacer US Export Leaders ETF
Anteil0.95%
First Trust Health Care Alphadex Fund
Anteil0.89%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
9.00M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jul 12, 2023
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2023 going ex on Jul 26, 2023
Jul 27, 2023
Aug 11, 2023
Jul 26, 2023
Dec 14, 2022
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2023 going ex on Jan 20, 2023
Jan 23, 2023
Feb 10, 2023
Jan 20, 2023
Jul 13, 2022
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2022 going ex on Jul 26, 2022
Jul 27, 2022
Aug 11, 2022
Jul 26, 2022
Dec 08, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2022 going ex on Jan 20, 2022
Jan 21, 2022
Feb 09, 2022
Jan 20, 2022
Jul 14, 2021
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2021 going ex on Jul 26, 2021
Jul 27, 2021
Aug 11, 2021
Jul 26, 2021
Jan 07, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2021 going ex on Jan 21, 2021
Jan 22, 2021
Feb 09, 2021
Jan 21, 2021
Jul 09, 2020
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 07, 2020 going ex on Jul 22, 2020
Jul 23, 2020
Aug 07, 2020
Jul 22, 2020
Jan 07, 2020
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2020 going ex on Jan 22, 2020
Jan 23, 2020
Feb 10, 2020
Jan 22, 2020
Aktien-Split
Datum
Art
Verhältnis
Dec 07, 2023
Split
1→4
Datum
Art
Verhältnis
Dec 07, 2023
Split
1→4
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Cooper Companies Inc?
Die fünf größten Anteilseigner von Cooper Companies Inc sind:
The Vanguard Group, Inc. hält 24.16M Aktien, was 12.15% der Gesamtaktien entspricht.
Capital World Investors hält 8.39M Aktien, was 4.22% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 9.76M Aktien, was 4.91% der Gesamtaktien entspricht.
T. Rowe Price Investment Management, Inc. hält 7.38M Aktien, was 3.71% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 8.66M Aktien, was 4.36% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 24.16M Aktien, was 12.15% der Gesamtaktien entspricht.
Capital World Investors hält 8.39M Aktien, was 4.22% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 9.76M Aktien, was 4.91% der Gesamtaktien entspricht.
T. Rowe Price Investment Management, Inc. hält 7.38M Aktien, was 3.71% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 8.66M Aktien, was 4.36% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Cooper Companies Inc?
Die drei wichtigsten Anteilseigner-Typen von Cooper Companies Inc sind:
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.
Wie viele Institutionen halten Anteile an Cooper Companies Inc (COO)?
Mit Stand vom 2025Q4 halten 1362 Institutionen Anteile an Cooper Companies Inc, mit einem Gesamtmarktwert von etwa 208.96M, was 111.56% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -0.18% gestiegen.
Was ist die größte Einnahmequelle von Cooper Companies Inc?
Am FY2025Q3 erzielte das Geschäft mit Sphere, other für Cooper Companies Inc den höchsten Umsatz in Höhe von 359.60M, was 33.91% des Gesamtumsatzes entspricht.
